2019/1

  • Identification of risk factors of most common lifestyle related diseases in the community pharmacy – a review of the literature
    Magdalena Waszyk-Nowaczyk, Martyna Niedźbała, Małgorzata Grobelna, Anna Ratka

PDF


  • Potential mechanisms responsible for the concurrence of diabetes type 2 and depressive symptoms in patients
    Aniela Zubek, Magdalena Skikowska, Daria Słomińska, Katarzyna Manikowska

PDF


  • Photodynamic therapy in dermatology
    Katarzyna Czajkowska, Mateusz Czajkowski, Marcin Matuszewski, Roman J. Nowicki, Małgorzata Sokołowska-Wojdyło

PDF


  • Sodium-glucose cotransporter 2 inhibitors – new drugs for the treatment of diabetes mellitus
    Adrianna Dadej, Daniela Dadej, Szymon Tomczak, Anna Jelińska

PDF


  • Selected dietary supplements for treating osteoarthritis
    Arkadiusz Jańczyk, Marek Sawczuk

PDF


  • Metabolic treatment in heart failure
    Bartosz Kopeć, Mateusz Sikora, Bolesław Banach, Tomasz Sroczyński, Andrzej Pawlik

PDF


  • Nrf2 as therapeutic target in prevention and therapy of civilization diseases
    Marta Cykowiak, Violetta Krajka-Kuźniak

PDF


  • Cardiovascular toxicity of axitinib treatment – a case report
    Zuzanna Synowiec, Katarzyna Sobańska, Edmund Grześkowiak, Anna Jabłecka

PDF


  • Urticaria induced by Centella asiatica – case report
    Katarzyna Korzeniowska, Katarzyna Malesza, Artur Cieślewicz

PDF


  • Rituximab therapy in early recurrence of FSGS after kidney transplantation – case report
    Aleksandra Musiała, Dorota Kamińska, Oktawia Mazanowska, Joanna Porażka, Magdalena Krajewska

PDF